Xenon Pharmaceuticals Balance Sheet Analysis

Assets, liabilities, and stockholders equity in billions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Xenon Pharmaceuticals Inc. (XENE) - Annual data in billions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Current Assets
Cash and Cash Equivalents0.140.150.590.180.050.140.12
Short-Term Investments0.480.490.530.380.130.000.00
Cash & Short-Term Investments0.630.640.590.550.180.140.12
Accounts Receivable0.000.000.000.000.000.000.00
Inventory0.000.000.000.000.000.000.00
Other Current Assets0.010.010.010.000.000.010.00
Total Current Assets0.640.640.600.560.180.140.12
Non-Current Assets
Property, Plant & Equipment (Net)0.020.020.020.010.010.000.00
Long-Term Investments0.130.290.130.000.000.000.00
Other Non-Current Assets0.010.010.010.000.000.000.00
Total Non-Current Assets0.160.320.150.010.010.000.00
Total Assets0.800.960.750.570.190.150.12
Current Liabilities
Accounts Payable0.010.010.020.000.000.010.00
Short-Term Debt0.010.000.000.000.000.000.00
Accrued Liabilities0.020.010.010.000.010.000.00
Deferred Revenue0.000.000.000.000.000.000.00
Other Current Liabilities0.010.010.010.010.000.030.00
Total Current Liabilities0.040.030.020.010.010.070.00
Non-Current Liabilities
Long-Term Debt0.010.010.010.010.000.010.02
Other Non-Current Liabilities0.000.000.000.000.00-0.040.00
Total Non-Current Liabilities0.010.010.010.010.00-0.030.02
Total Liabilities0.040.040.030.020.020.040.02
Stockholders' Equity
Common Stock1.461.441.070.780.410.000.00
Retained Earnings-0.90-0.67-0.49-0.36-0.28-0.25-0.21
Accumulated Other Comprehensive Income0.000.000.000.000.000.000.00
Additional Paid-in Capital0.200.160.140.120.050.040.04
Shares Outstanding0.080.080.060.050.000.000.00
Total Stockholders' Equity0.750.930.720.550.170.090.10
Total Liabilities & Equity0.800.960.750.570.190.150.12